Antigen-selective modulation of AAV immunogenicity with tolerogenic rapamycin nanoparticles enables successful vector re-administration
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Antigen-selective modulation of AAV immunogenicity with tolerogenic rapamycin nanoparticles enables successful vector re-administration
Authors
Keywords
-
Journal
Nature Communications
Volume 9, Issue 1, Pages -
Publisher
Springer Nature America, Inc
Online
2018-10-01
DOI
10.1038/s41467-018-06621-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Severe Toxicity in Nonhuman Primates and Piglets Following High-Dose Intravenous Administration of an Adeno-Associated Virus Vector Expressing Human SMN
- (2018) Christian Hinderer et al. HUMAN GENE THERAPY
- Tolerogenic nanoparticles restore the antitumor activity of recombinant immunotoxins by mitigating immunogenicity
- (2018) Ronit Mazor et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Human regulatory B cells in health and disease: therapeutic potential
- (2017) Claudia Mauri et al. JOURNAL OF CLINICAL INVESTIGATION
- Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65 -mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial
- (2017) Stephen Russell et al. LANCET
- Successful Repeated Hepatic Gene Delivery in Mice and Non-human Primates Achieved by Sequential Administration of AAV5 ch and AAV1
- (2017) Anna Majowicz et al. MOLECULAR THERAPY
- Long-term effects of systemic gene therapy in a canine model of myotubular myopathy
- (2017) Matthew Elverman et al. MUSCLE & NERVE
- Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy
- (2017) Jerry R. Mendell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hemophilia B Gene Therapy with a High-Specific-Activity Factor IX Variant
- (2017) Lindsey A. George et al. NEW ENGLAND JOURNAL OF MEDICINE
- AAV5–Factor VIII Gene Transfer in Severe Hemophilia A
- (2017) Savita Rangarajan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Long-term microdystrophin gene therapy is effective in a canine model of Duchenne muscular dystrophy
- (2017) Caroline Le Guiner et al. Nature Communications
- Overcoming the Host Immune Response to Adeno-Associated Virus Gene Delivery Vectors: The Race Between Clearance, Tolerance, Neutralization, and Escape
- (2017) Federico Mingozzi et al. Annual Review of Virology
- Tolerogenic nanoparticles to induce immunologic tolerance: Prevention and reversal of FVIII inhibitor formation
- (2016) Ai-Hong Zhang et al. CELLULAR IMMUNOLOGY
- Improving the efficacy and safety of biologic drugs with tolerogenic nanoparticles
- (2016) Takashi K. Kishimoto et al. Nature Nanotechnology
- Intramuscular administration of AAV overcomes pre-existing neutralizing antibodies in rhesus macaques
- (2016) Jenny A. Greig et al. VACCINE
- A translationally optimized AAV-UGT1A1 vector drives safe and long-lasting correction of Crigler-Najjar syndrome
- (2016) Giuseppe Ronzitti et al. Molecular Therapy-Methods & Clinical Development
- Hemophilia Gene Therapy: Caught Between a Cure and an Immune Response
- (2015) Roland W. Herzog MOLECULAR THERAPY
- Determination of Anti-Adeno-Associated Virus Vector Neutralizing Antibody Titer with anIn VitroReporter System
- (2015) Amine Meliani et al. Human Gene Therapy Methods
- AAV capsid CD8+ T-cell epitopes are highly conserved across AAV serotypes
- (2015) Daniel J Hui et al. Molecular Therapy-Methods & Clinical Development
- Life-Long Correction of Hyperbilirubinemia with a Neonatal Liver-Specific AAV-Mediated Gene Transfer in a Lethal Mouse Model of Crigler–Najjar Syndrome
- (2014) Giulia Bortolussi et al. HUMAN GENE THERAPY
- Long-Term Safety and Efficacy of Factor IX Gene Therapy in Hemophilia B
- (2014) Amit C. Nathwani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Polymeric synthetic nanoparticles for the induction of antigen-specific immunological tolerance
- (2014) Roberto A. Maldonado et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- B-cell depletion is protective against anti-AAV capsid immune response: a human subject case study
- (2014) M Corti et al. Molecular Therapy-Methods & Clinical Development
- Monogenic diseases that can be cured by liver transplantation
- (2013) Stefano Fagiuoli et al. JOURNAL OF HEPATOLOGY
- Modulation of CD8+ T cell responses to AAV vectors with IgG-derived MHC class II epitopes
- (2013) Daniel J Hui et al. MOLECULAR THERAPY
- Plasmapheresis Eliminates the Negative Impact of AAV Antibodies on Microdystrophin Gene Expression Following Vascular Delivery
- (2013) LG Chicoine et al. MOLECULAR THERAPY
- AAV8 Induces Tolerance in Murine Muscle as a Result of Poor APC Transduction, T Cell Exhaustion, and Minimal MHCI Upregulation on Target Cells
- (2013) Lauren E Mays et al. MOLECULAR THERAPY
- Overcoming Preexisting Humoral Immunity to AAV Using Capsid Decoys
- (2013) F. Mingozzi et al. Science Translational Medicine
- Assessment of a passive immunity mouse model to quantitatively analyze the impact of neutralizing antibodies on adeno-associated virus-mediated gene transfer
- (2012) Lan Sun et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Humoral and Cellular Capsid-Specific Immune Responses to Adeno-Associated Virus Type 1 in Randomized Healthy Donors
- (2012) P. Veron et al. JOURNAL OF IMMUNOLOGY
- Transient and intensive pharmacological immunosuppression fails to improve AAV-based liver gene transfer in non-human primates
- (2012) Carmen Unzu et al. Journal of Translational Medicine
- Pharmacological Modulation of Humoral Immunity in a Nonhuman Primate Model of AAV Gene Transfer for Hemophilia B
- (2012) Federico Mingozzi et al. MOLECULAR THERAPY
- AAV2 Gene Therapy Readministration in Three Adults with Congenital Blindness
- (2012) J. Bennett et al. Science Translational Medicine
- Hepatic Gene Transfer in Neonatal Mice by Adeno-Associated Virus Serotype 8 Vector
- (2011) Lili Wang et al. HUMAN GENE THERAPY
- A 10 Patient Case Report on the Impact of Plasmapheresis Upon Neutralizing Factors Against Adeno-associated Virus (AAV) Types 1, 2, 6, and 8
- (2011) Virginie Monteilhet et al. MOLECULAR THERAPY
- Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges
- (2011) Federico Mingozzi et al. NATURE REVIEWS GENETICS
- Adenovirus-Associated Virus Vector–Mediated Gene Transfer in Hemophilia B
- (2011) Amit C. Nathwani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prevalence of Serum IgG and Neutralizing Factors Against Adeno-Associated Virus (AAV) Types 1, 2, 5, 6, 8, and 9 in the Healthy Population: Implications for Gene Therapy Using AAV Vectors
- (2010) Sylvie Boutin et al. HUMAN GENE THERAPY
- Safety and Efficacy of Subretinal Readministration of a Viral Vector in Large Animals to Treat Congenital Blindness
- (2010) D. Amado et al. Science Translational Medicine
- High AAV vector purity results in serotype- and tissue-independent enhancement of transduction efficiency
- (2009) E Ayuso et al. GENE THERAPY
- Impact of the Underlying Mutation and the Route of Vector Administration on Immune Responses to Factor IX in Gene Therapy for Hemophilia B
- (2009) Ou Cao et al. MOLECULAR THERAPY
- A convenient enzyme-linked immunosorbent assay for rapid screening of anti-adeno-associated virus neutralizing antibodies
- (2009) T. Ito et al. ANNALS OF CLINICAL BIOCHEMISTRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now